19 December 2014 - CannaPharmaRx, the New Jersey-based pharmaceutical company, is collaborating with PharmaDirections, a pharmaceutical project management and consulting group.

It was reported yesterday that the collaboration is aimed at launching an R&D platform to investigate product opportunities in endocannabinoid science for commercialisation in global markets.

PharmaDirections' expertise is to help CannaPharmaRx with drug discovery, API process development, preclinical pharmacology and toxicology studies, formulation development, drug substance/drug product GMP manufacturing and regulatory submissions.